Biocodex is a French pharmaceutical company founded in 1953 to develop and market the world’s first probiotic yeast strain, Saccharomyces boulardii CNCM I-745®. Today, Biocodex focuses its business on three main areas: Microbiota care; Women’s health; Orphan diseases. With more than 1,600 employees, Biocodex generated net revenues of above €500 million in 2023, including 1/3 in France and 2/3 internationally. The group is present in more than 100 countries through wholly owned subsidiaries in 16 countries and a network of distributors worldwide. To report quality complaint(s) or adverse event(s) related to Biocodex products please visit https://www.biocoreport.com/en/
View Top Employees from BIOCODEXWebsite | http://www.biocodex.com |
Revenue | $412.5 million |
Employees | 1,405 (1,082 on RocketReach) |
Founded | 1953 |
Address | 7 Avenue Gallieni, Gentilly 94250, FR |
Technologies |
JavaScript,
HTML,
PHP
+55 more
(view full list)
|
Industry | Pharmaceutical Manufacturing, Manufacturing General, Gastroenterology, Manufacturing, Neurology/Psychiatry, Pain management, Pédiatry, Rheumatology, Otolaryngology |
Web Rank | 4 Million |
Keywords | Women's Health, Pharmaceutical Companies, Pharma, Drug Development And Manufacturing |
SIC | SIC Code 283 Companies, SIC Code 28 Companies, SIC Code 2834 Companies |
NAICS | NAICS Code 42 Companies, NAICS Code 32 Companies, NAICS Code 4242 Companies, NAICS Code 424 Companies, NAICS Code 325 Companies, NAICS Code 42421 Companies |
Looking for a particular BIOCODEX employee's phone or email?
The BIOCODEX annual revenue was $412.5 million in 2024.
1,082 people are employed at BIOCODEX.
The NAICS codes for BIOCODEX are [42, 32, 4242, 424, 325, 42421].
The SIC codes for BIOCODEX are [283, 28, 2834].